Petra Obrtlíková

MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia

Karin Vargová, Nikola Čuřík, Pavel Burda et al. · Blood · 2011 · 145 citations

Human embryonic stem cell−derived vascular progenitor cells capable of endothelial and smooth muscle cell function

Katherine Hill, Petra Obrtlíková, Diego F. Alvarez et al. · Experimental Hematology · 2010 · 83 citations · Full text

Progenitor Cells, Developmental Biology, Medicine +9

Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial

Richard Greil, Petra Obrtlíková, Lukáš Smolej et al. · The Lancet Haematology · 2016 · 46 citations

Hematological Malignancy, Second-line Rituximab-containing Chemoimmunotherapy, Lymphoid Neoplasia +10

Positron emission tomography at the end of first-line therapy and during follow-up in patients with Hodgkin lymphoma: a retrospective study

Heidi Móciková, Petra Obrtlíková, B Vacková et al. · Annals of Oncology · 2009 · 42 citations · Full text

Positron Emission Tomography, Retrospective Study, Lymphoid Neoplasia +8

Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a Phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic Leukemia

Carolina Moreno, Marco Montillo, Panayiotis Panayiotidis et al. · Haematologica · 2015 · 40 citations · Full text